Loading...
XSTO
ARJO B
Market cap745mUSD
Jul 22, Last price  
26.52SEK
1D
-0.15%
1Q
4.99%
IPO
8.91%
Name

Arjo AB (publ)

Chart & performance

D1W1MN
XSTO:ARJO B chart
P/E
21.63
P/S
0.66
EPS
1.23
Div yield, %
3.58%
Shrs. gr., 5y
Rev. gr., 5y
3.92%
Revenues
11.00b
-2.59%
7,568,000,0008,115,000,0007,808,000,0007,688,000,0008,217,000,0008,925,000,0009,078,000,0009,070,000,0009,979,000,00010,980,000,00011,292,000,00011,000,000,000
Net income
334m
-32.93%
619,000,000307,000,000490,000,000118,000,000296,000,000403,000,000526,000,000742,000,000449,000,000480,000,000498,000,000334,000,000
CFO
1.44b
-5.34%
959,000,000811,000,000919,000,000572,000,000991,000,0001,252,000,0002,267,000,0001,734,000,000915,000,0002,061,000,0001,516,000,0001,435,000,000
Dividend
Apr 23, 20260.95 SEK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Arjo AB (publ), a company established in 1957 and based in Malmö, Sweden, specializes in developing and marketing healthcare technologies and services. The firm focuses on aiding individuals facing reduced mobility and age-related health issues, with operations spanning North America, Western Europe, and various other international regions. Their comprehensive product line encompasses equipment for patient handling, sanitation, disinfection, and medical beds. Additionally, Arjo provides advanced solutions for the prevention and treatment of pressure injuries, leg ulcers, deep vein thrombosis, and edema, alongside diagnostic tools for obstetric and cardiac care. Complementing their product offerings, the company delivers specialized room assessment services for dementia and bariatric patients, clinical advisory, maintenance support, and flexible equipment rental and financing plans. Arjo's clientele primarily consists of private and public healthcare facilities offering both acute and long-term care.
IPO date
Dec 12, 2017
Employees
6,800
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT